Elekta saw the highest growth of 1.72% in patent filings and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.72% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Elekta’s patent filings and grants. Buy the databook here.
Elekta has been focused on protecting inventions in United States(US) with 28 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 31% filings and 50% grants. The United States(US), United Kingdom(GB), European Patent Office(EPO), and China(CN) patent Office are among the top ten patent offices where Elekta is filings its patents. Among the top granted patent authorities, Elekta has 50% of its grants in United States(US), 18% in European Patent Office(EPO) and 18% in China(CN).
Siemens and Koninklijke Philips could be the strongest competitors for Elekta
Patents related to healthtech and artificial intelligence lead Elekta's portfolio
Elekta has the highest number of patents in healthtech followed by, artificial intelligence and machine learning. For healthtech, nearly 27% of patents were filed and 16% of patents were granted in Q2 2024.
Diagnostic imaging related patents lead Elekta portfolio followed by image management, and mos micro (mpu, mcu & dsp)
Elekta has highest number of patents in diagnostic imaging followed by image management, mos micro (mpu, mcu & dsp), healthcare it, and digital signal processors(dsp). For diagnostic imaging, nearly 23% of patents were filed and 19% of patents were granted in Q2 2024.
For comprehensive analysis of Elekta's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.